Non-Response and Cost Effectiveness Analysis of Interferon Therapies in Management of Chronic Hepatitis C Patients.دراسة عدم الاستجابة و جدوى تكلفة العلاج بالانترفيرون فى مرضى الالتهاب الكبدى المزمن (سى).
Rita Raafat Gad;
Abstract
Hepatitis C virus infects about 170 million people worldwide. The morbidity and mortality related to chronic hepatitis C is a major public health issue in Egypt where HCV prevalence nationwide is estimated around 12%. Genotype 4 represents over 90% of cas
Other data
| Title | Non-Response and Cost Effectiveness Analysis of Interferon Therapies in Management of Chronic Hepatitis C Patients.دراسة عدم الاستجابة و جدوى تكلفة العلاج بالانترفيرون فى مرضى الالتهاب الكبدى المزمن (سى). | Authors | Rita Raafat Gad | Keywords | Non-Response and Cost Effectiveness Analysis of Interferon Therapies in Management of Chronic Hepatitis C Patients. دراسة عدم الاستجابة و جدوى تكلفة العلاج بالانترفيرون فى مرضى الالتهاب الكبدى المزمن (سى). | Issue Date | 2008 | Description | Hepatitis C virus infects about 170 million people worldwide. The morbidity and mortality related to chronic hepatitis C is a major public health issue in Egypt where HCV prevalence nationwide is estimated around 12%. Genotype 4 represents over 90% of cas |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.